SH3BP5 and cancer: Thus, targeting molecules in JNK-SAB-ROS activation loop is a promising strategy to promote cell death, such as in cancer cells [76,77], and to prevent cell death, such as in hepatotoxicity [7,12,65], liver and kidney injury in septic shock, and ischemia/reperfusion injury in heart and brain [78,79,80,81].